Inactive Instrument
Celator Pharmaceuticals Inc Stock
Stocks
US15089R1023
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 16-05-31 | Celator Pharmaceuticals : Jazz Pharma to buy Celator in $1.5 billion deal | RE |
| 16-05-31 | Celator Pharmaceuticals : Jazz Pharma nears deal to buy Celator for about $1.5 billion - WSJ | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Arthur C. Louie
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +3.41% | +6.32% | +16.27% | 50.03B | |
| -0.69% | +6.25% | +492.36% | +585.40% | 44.36B | |
| +0.08% | +11.23% | +23.99% | +81.74% | 40.82B | |
| +0.76% | +6.85% | +35.40% | +10.92% | 39.83B | |
| +4.73% | +13.29% | +27.76% | +54.22% | 32.51B | |
| -0.41% | +4.08% | - | - | 16.85B | |
| +0.51% | +5.29% | +34.62% | +126.87% | 16.81B | |
| -0.20% | +1.57% | +5.49% | +21.35% | 14.05B | |
| +1.81% | +20.45% | +89.35% | +31.49% | 13.22B | |
| Average | +0.65% | +283.03% | +89.41% | +116.03% | 29.83B | |
| Weighted average by Cap. | +0.53% | +297.81% | +108.45% | +139.75% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
